Monte Rosa Therapeutics filed transactions via SEC Form 4 on June 29, involving Chief Medical Officer Filip Janku.
1 report, 1 independent
Updated Jun 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Monte Rosa Therapeutics filed transactions via SEC Form 4 on June 29, involving Chief Medical Officer Filip Janku.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Monte Rosa Therapeutics
biotechnology company
Nothing else this week.
-
SEC
Slovak company
Related events
- Doximity, a company serving the U.S. healthcare practitioner community, has made a required filing with the SEC under Form 4 rules.
- TransMedics Group, Inc. filed required reports with the SEC on August 27, 2026.
- Omada Health filed transaction details with the SEC on September 23, 2026.
- Criteo filed documents with the SEC on August 31, 2026.
- Curtis E. Garner, President and CTO of Chipotle Mexican Grill, filed a Form 4 with the SEC.